Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 YearsBenzinga • about 17 hours ago
read more...
Share to Feed
Is Viking Therapeutics Incredibly Undervalued...
Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024 Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024 PR Newswire SAN...
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics...
Forget Viking Therapeutics. Here's 1 Weight-Loss Stock to Keep Your Eyes on Instead...
Viking Therapeutics Is Great. Here's Why You Shouldn't Buy It...
One of the hottest areas of the pharmaceutical industry right now is the weight loss treatment space. Novo Nordisk and Eli Lilly have been the primary innovators. Their groundbreaking glucagon-like...
Viking Therapeutics (NASDAQ: VKTX) is on a tear this year, with shares catapulting upward by 340% thanks to good data (and high expectations) from one of its mid-stage clinical trials testing a...
Viking Therapeutics is preparing to be the next entry into the GLP-1 Market, and VKTX stock is soaring as analysts start to bid the stock higher...